Peter Ruf
Puchheim, BY 82178, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Evaluation of leukocyte depletion filters for the removal of EpCAM-positive tumor cells during oncologic intraoperative blood salvage using CATUVAB®: an exploratory feasibility study.
Journal: BMC anesthesiology
Published: February 17, 2026
Combination of GD2-directed bispecific trifunctional antibody therapy with Pd-1 immune checkpoint blockade induces anti-neuroblastoma immunity in a syngeneic mouse model.
Journal: Frontiers in immunology
Published: August 19, 2022
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma.
Journal: Journal for immunotherapy of cancer
Published: June 18, 2021
Removal of EpCAM-positive tumor cells from blood collected during major oncological surgery using the Catuvab device- a pilot study.
Journal: BMC anesthesiology
Published: February 24, 2021
First time intravesically administered trifunctional antibody catumaxomab in patients with recurrent non-muscle invasive bladder cancer indicates high tolerability and local immunological activity.
Journal: Cancer immunology, immunotherapy : CII
Published: November 11, 2020
Immunotherapy with the trifunctional anti-CD20 × anti-CD3 antibody FBTA05 in a patient with relapsed t(8;14)-positive post-transplant lymphoproliferative disease.
Journal: Leukemia & lymphoma
Published: January 18, 2017
Potent CD4+ T cell-associated antitumor memory responses induced by trifunctional bispecific antibodies in combination with immune checkpoint inhibition.
Journal: Oncotarget
Published: July 25, 2016
Efficacy and Tolerability of a GD2-Directed Trifunctional Bispecific Antibody in a Preclinical Model: Subcutaneous Administration Is Superior to Intravenous Delivery.
Journal: Molecular cancer therapeutics
Published: February 17, 2015
Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspects.
Journal: Archives of gynecology and obstetrics
Published: February 11, 2015
Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model.
Journal: Journal of translational medicine
Published: September 07, 2012
Last Updated: 09/26/2026